Posted by Michael Wonder on 08 Dec 2021
Improvements to clinical trials will strengthen Australia’s economy and benefit patients
8 December 2021 - Clinical trials in Australia need improvements if we are to increase our global competitiveness says Medicines Australia in a new paper released today.
Clinical trials provide benefits to patients, the healthcare system and the economy. The COVID-19 pandemic has shown how quickly innovative medicines, therapeutics and vaccines can evolve.
Encouraging the global biopharmaceutical industry to invest in Australian clinical trials creates highly skilled jobs, a more competitive economy and places Australian patients at the front of the queue for innovative treatments.
